Treclinac

Medicinal product

(Invented) name

Treclinac

Active substance (s)

Klindamicinas/Tretinoinas

Strength

10 mg/0,25 mg/g

Pharmaceutical form

gelis

Route (s) of administration

vartoti ant odos

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

D10AF51, Clindamycin, combinations

Marketing authorisation holder

Viatris Healthcare Limited, Airija

Date of authorisation

2013-04-26

Date of renewal

2018-04-12

Documents

3279 Pakuotės lapelis 2024 10 24.docx

3279 Treclinac PCS PL 2024 10 24.docx

Stage

Perregistruotas

Controlled?

No

Controlled substance type

Legal basis

10b

Procedure number

SE/H/1134/001/DC

Marketing authorisation procedure

Decentralizuota procedūra

Qualitative and quantitative composition

Viename g gelio yra	1 g
Klindamicinas	10 mg
Tretinoinas	0,25 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
45985	59790	1059790	tūbelė	30 g N1		Receptinis	LT/1/13/3279/001	Tiekiama	-	-	No	-	-	Download
56047	70102	1070102	tūbelė	60 g N1		Receptinis	LT/1/13/3279/002	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2018-04-12	Perregistruotas
2013-04-26	Registruotas